
Invitae Corporation NVTA
Quartalsbericht 2023-Q3
hinzugefügt 08.11.2023
Invitae Corporation DSO 2011-2025 | NVTA
DSO Jährlich Invitae Corporation
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 242 | 165 | 52.4 | 54.8 | 65 | 55.8 | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 242 | 52.4 | 106 |
DSO Vierteljährlich Invitae Corporation
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 63.3 | 64.8 | 70.7 | - | 58.7 | 54.4 | 54.1 | 45.1 | 45.5 | 39.7 | 41.1 | 43.4 | 63.4 | 94.3 | 57 | 44.8 | 52.5 | 55.5 | 66.2 | 52.9 | 64.2 | 64.3 | 60.5 | 37.4 | 52.4 | 66.3 | 51.1 | 11.4 | 16.8 | 18.9 | 13.3 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 94.3 | 11.4 | 50.8 |
DSO anderer Aktien in der Diagnostik & Forschung
| Name | DSO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
145 | - | -6.23 % | $ 30.6 M | ||
|
Akumin
AKU
|
57.4 | - | -17.87 % | $ 25.9 M | ||
|
Burning Rock Biotech Limited
BNR
|
31.7 | $ 15.75 | -7.62 % | $ 169 M | ||
|
Accelerate Diagnostics
AXDX
|
291 | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
112 | - | -13.05 % | $ 7.29 M | ||
|
BioNano Genomics
BNGO
|
83.4 | $ 1.62 | -2.41 % | $ 2.06 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
90.8 | - | - | $ 562 M | ||
|
Castle Biosciences
CSTL
|
49.2 | $ 38.63 | 1.74 % | $ 1.07 B | ||
|
Chembio Diagnostics
CEMI
|
66.3 | - | 0.22 % | $ 16.8 M | ||
|
Danaher Corporation
DHR
|
57 | $ 226.33 | -2.6 % | $ 165 B | ||
|
DarioHealth Corp.
DRIO
|
85.8 | $ 11.89 | -6.82 % | $ 337 M | ||
|
DexCom
DXCM
|
85 | $ 66.96 | - | $ 25.8 B | ||
|
IQVIA Holdings
IQV
|
78 | $ 222.26 | - | $ 40.3 B | ||
|
Fulgent Genetics
FLGT
|
77.4 | $ 27.14 | 0.3 % | $ 821 M | ||
|
Global Cord Blood Corporation
CO
|
112 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
67.2 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
11.7 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
122 | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
80.6 | - | -11.32 % | $ 2.94 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
98.1 | - | - | $ 10.7 B | ||
|
CareDx, Inc
CDNA
|
76.4 | $ 20.56 | 3.84 % | $ 1.11 B | ||
|
Enzo Biochem
ENZ
|
50.3 | - | -8.98 % | $ 14.8 K | ||
|
Anixa Biosciences
ANIX
|
385 | $ 3.58 | - | $ 114 K | ||
|
Exact Sciences Corporation
EXAS
|
29.9 | $ 101.5 | - | $ 18.8 B | ||
|
Co-Diagnostics
CODX
|
101 | $ 0.34 | - | $ 9.98 M | ||
|
Guardant Health
GH
|
49.2 | $ 102.07 | - | $ 12.5 B | ||
|
Aspira Women's Health
AWH
|
50.7 | - | -6.19 % | $ 10.5 M | ||
|
Heska Corporation
HSKA
|
40.8 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
101 | - | -20.0 % | $ 1.06 M | ||
|
Illumina
ILMN
|
61.3 | $ 134.87 | - | $ 21.4 B | ||
|
Charles River Laboratories International
CRL
|
67.7 | $ 193.03 | - | $ 9.92 B | ||
|
Quotient Limited
QTNT
|
45.1 | - | -11.32 % | $ 1.1 M | ||
|
Quest Diagnostics Incorporated
DGX
|
46.5 | $ 182.56 | - | $ 20.3 B | ||
|
Biodesix
BDSX
|
41.7 | $ 7.85 | -2.12 % | $ 1.02 B | ||
|
Laboratory Corporation of America Holdings
LH
|
54.1 | $ 264.18 | -0.21 % | $ 22.2 B | ||
|
ICON Public Limited Company
ICLR
|
68.5 | $ 186.58 | - | $ 15.4 B | ||
|
IDEXX Laboratories
IDXX
|
43.6 | $ 704.2 | - | $ 58.1 B | ||
|
Mettler-Toledo International
MTD
|
63.7 | $ 1 393.64 | - | $ 29.6 B | ||
|
Lantheus Holdings
LNTH
|
72 | $ 66.62 | - | $ 4.61 B | ||
|
Agilent Technologies
A
|
63.8 | $ 139.68 | 0.01 % | $ 42.5 B | ||
|
Myriad Genetics
MYGN
|
51.3 | $ 7.21 | - | $ 653 M | ||
|
NeoGenomics
NEO
|
77.8 | $ 11.85 | - | $ 1.5 B | ||
|
Biomerica
BMRA
|
57.7 | $ 2.58 | - | $ 5.93 M | ||
|
Neogen Corporation
NEOG
|
66.6 | $ 6.86 | -2.56 % | $ 1.49 B | ||
|
Bioventus
BVS
|
92.3 | $ 7.55 | 1.75 % | $ 473 M | ||
|
Motus GI Holdings
MOTS
|
77.2 | - | -34.28 % | $ 263 K |